盘龙药业
(002864)
| 流通市值：20.75亿 | | | 总市值：28.78亿 |
| 流通股本：9859.67万 | | | 总股本：1.37亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 422,577,795.93 | 222,541,696.37 | 1,140,869,253.68 | 841,452,392.85 |
| 营业总成本 | 365,381,496.48 | 189,458,728.35 | 1,018,736,848.08 | 735,238,373.82 |
| 其他经营收益 | | | | |
| 营业利润 | 60,155,653.85 | 35,400,309.74 | 110,120,622.43 | 107,939,366.87 |
| 利润总额 | 58,199,014.8 | 33,590,439.25 | 108,951,678.16 | 106,709,241.3 |
| 净利润 | 42,305,825.32 | 21,735,278.4 | 96,021,548.69 | 89,602,427.86 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 42,305,825.32 | 21,735,278.4 | 96,021,548.69 | 89,602,427.86 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,828,182,004.47 | 1,918,083,441.15 | 1,802,777,131.9 | 1,876,878,524.25 |
| 非流动资产: | | | | |
| 非流动资产合计 | 518,621,542.24 | 514,321,474.55 | 520,009,581.05 | 524,153,995.45 |
| 资产总计 | 2,346,803,546.71 | 2,432,404,915.7 | 2,322,786,712.95 | 2,401,032,519.7 |
| 流动负债: | | | | |
| 流动负债合计 | 498,930,479.37 | 509,945,764.71 | 524,152,151.75 | 603,981,692.81 |
| 非流动负债: | | | | |
| 非流动负债合计 | 110,421,996.09 | 211,689,792.62 | 109,600,481.23 | 111,332,341.66 |
| 负债合计 | 609,352,475.46 | 721,635,557.33 | 633,752,632.98 | 715,314,034.47 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,735,321,542.82 | 1,708,595,220.37 | 1,686,834,271.67 | 1,683,956,206.54 |
| 股东权益合计 | 1,737,451,071.25 | 1,710,769,358.37 | 1,689,034,079.97 | 1,685,718,485.23 |
| 负债和股东权益合计 | 2,346,803,546.71 | 2,432,404,915.7 | 2,322,786,712.95 | 2,401,032,519.7 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 546,330,397.89 | 268,777,467.73 | 1,211,298,404.35 | 907,591,251.68 |
| 经营活动现金流出小计 | 369,808,755.17 | 175,771,630.86 | 1,148,287,789.16 | 818,435,303.35 |
| 经营活动产生的现金流量净额 | 176,521,642.72 | 93,005,836.87 | 63,010,615.19 | 89,155,948.33 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 221,491.37 | 254.95 | 283,416.56 | 283,204.17 |
| 投资活动现金流出小计 | 17,729,028.52 | 8,790,817.09 | 42,405,951.78 | 48,091,241.43 |
| 投资活动产生的现金流量净额 | -17,507,537.15 | -8,790,562.14 | -42,122,535.22 | -47,808,037.26 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 155,811,660 | 150,000,000 | 51,500,000 | 50,000,000 |
| 筹资活动现金流出小计 | 212,709,953.73 | 98,987,011.95 | 146,872,536.16 | 96,093,434.63 |
| 筹资活动产生的现金流量净额 | -56,898,293.73 | 51,012,988.05 | -95,372,536.16 | -46,093,434.63 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 102,115,811.84 | 135,228,262.78 | -74,484,456.19 | -4,745,523.56 |
| 期末现金及现金等价物余额 | 1,197,006,544.81 | 1,230,118,995.75 | 1,094,890,732.97 | 1,164,629,665.6 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 102,115,811.84 | - | -74,484,456.19 | - |
最新报告期：2026-08-31| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 长城证券 | 刘鹏,蔡航 | 0.74 | 0.80 | 0.90 | 2026-08-31 |
| 长城证券 | 刘鹏,蔡航 | 1.26 | 1.42 | 1.62 | 2026-07-13 |